These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29107757)

  • 21. Review of Economic Submissions to NICE Medical Technologies Evaluation Programme.
    Alshreef A; Jenks M; Green W; Dixon S
    Appl Health Econ Health Policy; 2016 Dec; 14(6):623-634. PubMed ID: 27480537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical procedures and non-surgical devices for the management of non-apnoeic snoring: a systematic review of clinical effects and associated treatment costs.
    Main C; Liu Z; Welch K; Weiner G; Jones SQ; Stein K
    Health Technol Assess; 2009 Jan; 13(3):iii, xi-xiv, 1-208. PubMed ID: 19091167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical devices early assessment methods: systematic literature review.
    Markiewicz K; van Til JA; IJzerman MJ
    Int J Technol Assess Health Care; 2014 Apr; 30(2):137-46. PubMed ID: 24805836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When Future Change Matters: Modeling Future Price and Diffusion in Health Technology Assessments of Medical Devices.
    Grimm SE; Dixon S; Stevens JW
    Value Health; 2016; 19(6):720-726. PubMed ID: 27712696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A primer on the assessment of medical technologies.
    Matuszewski KA
    Pharm Pract Manag Q; 1997 Jan; 16(4):53-65. PubMed ID: 10164160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of health outcomes.
    Thavorncharoensap M
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S27-32. PubMed ID: 24964696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The GRACE checklist for rating the quality of observational studies of comparative effectiveness: a tale of hope and caution.
    Dreyer NA; Velentgas P; Westrich K; Dubois R
    J Manag Care Spec Pharm; 2014 Mar; 20(3):301-8. PubMed ID: 24564810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrinsic properties of medical devices: considerations for economic evaluation.
    Basu R; Eggington S
    Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):619-626. PubMed ID: 31721598
    [No Abstract]   [Full Text] [Related]  

  • 32. Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey.
    Hatz MH; Schreyögg J; Torbica A; Boriani G; Blankart CR
    Health Econ; 2017 Feb; 26 Suppl 1():124-144. PubMed ID: 28139093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is a rapid review? A methodological exploration of rapid reviews in Health Technology Assessments.
    Harker J; Kleijnen J
    Int J Evid Based Healthc; 2012 Dec; 10(4):397-410. PubMed ID: 23173665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Guidelines: A NICE Way to Introduce Cost-Effectiveness Considerations?
    Drummond M
    Value Health; 2016; 19(5):525-30. PubMed ID: 27565268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health technology assessment of medical devices: a survey of non-European union agencies.
    Ciani O; Wilcher B; Blankart CR; Hatz M; Rupel VP; Erker RS; Varabyova Y; Taylor RS
    Int J Technol Assess Health Care; 2015 Jan; 31(3):154-65. PubMed ID: 26044729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASSESSING THE VALUE OF INNOVATIVE MEDICAL DEVICES AND DIAGNOSTICS: THE IMPORTANCE OF CLEAR AND RELEVANT CLAIMS OF BENEFIT.
    Campbell B; Campbell M; Dobson L; Higgins J; Dillon B; Marlow M; Pomfrett CJD
    Int J Technol Assess Health Care; 2018 Jan; 34(4):419-424. PubMed ID: 30025548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.
    Thurgar E; Barton S; Karner C; Edwards SJ
    Health Technol Assess; 2016 Mar; 20(24):v-vi, 1-486. PubMed ID: 27034016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for health technologies: specific guidance for oncology products in Canada.
    Mittmann N; Evans WK; Rocchi A; Longo CJ; Au HJ; Husereau D; Leighl NB; Isogai PK; Krahn MD; Peacock S; Marshall D; Coyle D; Taylor SC; Jacobs P; Oh PI
    Value Health; 2012 May; 15(3):580-5. PubMed ID: 22583470
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.